<DOC>
	<DOC>NCT00715286</DOC>
	<brief_summary>To determine the impact of Neoadjuvant chemotherapy on surgical debulking rate, overall and disease-free survival and quality of life (QOL) in patients with advanced EOC.</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms, Glandular and Epithelial</mesh_term>
	<criteria>Age:20 to 65 years Epithelial ovarian carcinoma Stage IIIc &amp; IV (pleural effusion only) ECOG PS 02 Cytology/biopsy positive patients Good compliance Previously untreated patients Any medical contraindication of surgery Psychiatric illness Cardiac, liver or renal dysfunction</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>epithelial ovarian cancer</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>randomized study</keyword>
</DOC>